Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1987 1
1989 1
1991 1
1992 1
1993 1
1994 2
1996 1
1997 1
1998 1
1999 3
2000 3
2002 9
2003 10
2004 4
2005 6
2006 5
2007 11
2008 14
2009 10
2010 14
2011 18
2012 12
2013 19
2014 16
2015 16
2016 14
2017 11
2018 6
2019 9
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

202 results
Results by year
Filters applied: . Clear all
Page 1
Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP).
Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, Stefanovic V, Tutschek B, Chantraine F; European Working Group on Abnormally Invasive Placenta (EW-AIP). Collins SL, et al. Among authors: Ashcroft A. Ultrasound Obstet Gynecol. 2016 Mar;47(3):271-5. doi: 10.1002/uog.14952. Ultrasound Obstet Gynecol. 2016. PMID: 26205041 Free article. No abstract available.
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Cook G, Ashcroft AJ, Cairns DA, Williams CD, Brown JM, Cavenagh JD, Snowden JA, Parrish C, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Chown S, Heartin E, O'Connor S, Drayson MT, Hockaday A, Morris TC; National Cancer Research Institute Haemato-oncology Clinical Studies Group. Cook G, et al. Among authors: Ashcroft AJ. Lancet Haematol. 2016 Jul;3(7):e340-51. doi: 10.1016/S2352-3026(16)30049-7. Lancet Haematol. 2016. PMID: 27374467 Free article. Clinical Trial.
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Ahmedzai SH, Snowden JA, Ashcroft AJ, Cairns DA, Williams C, Hockaday A, Cavenagh JD, Ademokun D, Tholouli E, Allotey D, Dhanapal V, Jenner M, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Parrish C, Brown JM, Morris TCM, Cook G; National Cancer Research Institute Haemato-Oncology Clinical Studies Group. Ahmedzai SH, et al. Among authors: Ashcroft AJ. J Clin Oncol. 2019 Jul 1;37(19):1617-1628. doi: 10.1200/JCO.18.01006. Epub 2019 Apr 10. J Clin Oncol. 2019. PMID: 30969846 Free PMC article.
Mass spectrometry-based studies of virus assembly.
Ashcroft AE. Ashcroft AE. Curr Opin Virol. 2019 Jun;36:17-24. doi: 10.1016/j.coviro.2019.02.006. Epub 2019 Mar 9. Curr Opin Virol. 2019. PMID: 30861488 Review.
Small molecule probes of protein aggregation.
Young LM, Ashcroft AE, Radford SE. Young LM, et al. Among authors: Ashcroft AE. Curr Opin Chem Biol. 2017 Aug;39:90-99. doi: 10.1016/j.cbpa.2017.06.008. Epub 2017 Jun 22. Curr Opin Chem Biol. 2017. PMID: 28649012 Free article. Review.
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Cook G, Royle KL, O'Connor S, Cairns DA, Ashcroft AJ, Williams CD, Hockaday A, Cavenagh JD, Snowden JA, Ademokun D, Tholouli E, Andrews VE, Jenner M, Parrish C, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Drayson MT, Brown JM, Morris TCM; National Cancer Research Institute Haemato-oncology Clinical Studies Group. Cook G, et al. Among authors: Ashcroft AJ. Br J Haematol. 2019 May;185(3):450-467. doi: 10.1111/bjh.15782. Epub 2019 Feb 6. Br J Haematol. 2019. PMID: 30729512 Free PMC article.
Identification of a novel site of interaction between ataxin-3 and the amyloid aggregation inhibitor polyglutamine binding peptide 1.
Knight PD, Karamanos TK, Radford SE, Ashcroft AE. Knight PD, et al. Among authors: Ashcroft AE. Eur J Mass Spectrom (Chichester). 2018 Feb;24(1):129-140. doi: 10.1177/1469066717729298. Epub 2017 Aug 29. Eur J Mass Spectrom (Chichester). 2018. PMID: 29334808 Free PMC article.
Prices of IUCr journals.
Ashcroft AT. Ashcroft AT. Acta Crystallogr A Found Adv. 2018 Nov 1;74(Pt 6):710-711. doi: 10.1107/S2053273318014699. Epub 2018 Oct 30. Acta Crystallogr A Found Adv. 2018. PMID: 30378583 No abstract available.
Pregnancy and ketoacidosis: Is pancreatitis a missing link?
Frise CJ, Ashcroft A, Jones BA, Mackillop L. Frise CJ, et al. Among authors: Ashcroft A. Obstet Med. 2016 Jun;9(2):60-3. doi: 10.1177/1753495X15612330. Epub 2015 Nov 30. Obstet Med. 2016. PMID: 27512495 Free PMC article. Review.
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial.
Striha A, Ashcroft AJ, Hockaday A, Cairns DA, Boardman K, Jacques G, Williams C, Snowden JA, Garg M, Cavenagh J, Yong K, Drayson MT, Owen R, Cook M, Cook G. Striha A, et al. Among authors: Ashcroft AJ. Trials. 2018 Mar 7;19(1):169. doi: 10.1186/s13063-018-2524-8. Trials. 2018. PMID: 29514706 Free PMC article. Clinical Trial.
202 results
Jump to page
Feedback